-
-
Mineralocorticoid receptor blockers have demonstrated improved survival in class III-IV heart-failure patients (spironolactone) and post-acute myocardial infarction patients with systolic dysfunction heart failure (eplerenone).
-
The randomized evaluation of long-term anticoagulation Therapy (RE-LY) trial was a study that compared two doses of a new direct-thrombin inhibitor, dabigatran, to warfarin for stroke prevention in patients with atrial fibrillation.
-
Coronary artery anomalies are being recognized with increasing frequency due to the increased usage of computed tomography (CT) and magnetic resonance imaging (MRI) scans in patients with chest pain syndromes.
-
Most prior study results of catheter ablation for atrial fibrillation (AF) have had relatively short follow-up duration.
-
Thrombosis of prosthetic heart valves is one of the most feared complications of heart-valve replacement.
-
-
Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
This paper reports results from the resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). This was a multicenter, double-blind, randomized trial testing the hypothesis that addition of resynchronization therapy (CRT) to an ICD, compared to an ICD only in patients with New York Heart Association (NYHA) class II or class III symptoms, left ventricular systolic dysfunction, and a widened QRS complex would improve survival and reduce hospitalizations.
-
This paper describes the results of a study which compared two energy types, cryoenergy and radiofrequency (RF), for catheter ablation in patients with atrioventricular nodal reentrant tachycardia (AVNRT).
